Charles Ryhee
Stock Analyst
(n/a)
# 4,650
Out of 4,652 analysts
25
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WBA Walgreens Boots Alliance | Maintains: Buy | $16 → $14 | $9.01 | +55.38% | 6 | Oct 22, 2024 | |
| CVS CVS Health | Upgrades: Buy | $59 → $85 | $54.03 | +57.32% | 4 | Oct 4, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $617.66 | +5.56% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $155.29 | +9.47% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $14.44 | +308.59% | 2 | Jan 30, 2023 | |
| RCM R1 RCM | Maintains: Outperform | $34 → $25 | $14.29 | +74.95% | 1 | Nov 14, 2022 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $123.51 | -41.71% | 1 | Aug 16, 2022 | |
| OTRK Ontrak | Downgrades: Underperform | $3,150 → $810 | $1.86 | +43,448.39% | 2 | Aug 20, 2021 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $9.70 | +1,838.14% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $13.56 | +113.86% | 1 | Mar 29, 2021 |
Walgreens Boots Alliance
Oct 22, 2024
Maintains: Buy
Price Target: $16 → $14
Current: $9.01
Upside: +55.38%
CVS Health
Oct 4, 2024
Upgrades: Buy
Price Target: $59 → $85
Current: $54.03
Upside: +57.32%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $617.66
Upside: +5.56%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $155.29
Upside: +9.47%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $14.44
Upside: +308.59%
R1 RCM
Nov 14, 2022
Maintains: Outperform
Price Target: $34 → $25
Current: $14.29
Upside: +74.95%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $123.51
Upside: -41.71%
Ontrak
Aug 20, 2021
Downgrades: Underperform
Price Target: $3,150 → $810
Current: $1.86
Upside: +43,448.39%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $9.70
Upside: +1,838.14%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $13.56
Upside: +113.86%